Breast Cancer
Needle-localized open breast biopsy used to diagnose breast lesions
Published in Women's Health Weekly, January 19th, 2006
Researchers in Austria conducted a study "to retrospectively determine the lesion miss rate and false-negative rate of NLOBB with stereotactic guidance in a large study population. The ethical review board approved the study; the need for informed consent was waived. A total of 1115 stereotactic NLOBBs performed in 1068 women aged 22-90 years (mean age, 54 years) were tracked to determine outcomes."
"In cases of malignancy, NLOBB was considered to be diagnostically successful. The mammographic outcomes in all patients with benign results...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Acute Coronary Syndromes
Differences in management of women post-ACS leads to increased rehospitalization - Breast Cancer Risk Factor
Women with history of ovarian cysts show decreased risk of breast cancer - Coronary Artery Bypass Graft
Increasing number of coronary artery bypass grafts for women may result in burdensome cost - Endometrial Ablation
Good outcomes and patient satisfaction were observed for women treated with Cavaterm plus - Hypertension
Ethnic differences are prevalent in hypertension rates among women - Acute Coronary Syndromes
Acute coronary syndrome in postmenopausal women may be associated with ACE-DD genotype - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
